» Articles » PMID: 8332102

Immune Suppressive Effects of Helicobacter Pylori on Human Peripheral Blood Mononuclear Cells

Overview
Date 1993 May 1
PMID 8332102
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Helicobacter pylori, the causative agent of type-B gastritis and duodenal ulcer in man is described as a bacterium able to stimulate the human immune system. This study demonstrates that H. pylori besides this property possesses an immune suppressive activity. The in vitro proliferation of human peripheral blood mononuclear cells to purified protein derivative of tuberculin (PPD), phytohemagglutinin, and concanavalin A was reduced in a dose-dependent manner by bacteria which had been inactivated by incubation at 56 degrees C as well as by a soluble cytoplasmic fraction of H. pylori. The immune suppressive effect on the mitogen-induced proliferation could be increased by preincubation of the mononuclear cells with H. pylori. The observed effect does not seem to be a specific phenomenon depending on prior exposure of the blood donors to H. pylori, since suppression occurred with mononuclear cells of H. pylori-infected patients as well as of antibody-negative healthy control individuals. The suppressive activity was non-dialyzable, heat-labile (100 degrees C, 30 min) and sensitive to trypsin. Furthermore, the treatment at 100 degrees C caused an increase in the capability of H. pylori to induce lymphoproliferation. This fact indicates that the suppressive factor is also effective on H. pylori antigens. While exogenous interleukin-2, could to a certain extent, restore the responsiveness of the lymphocytes after PPD-stimulation in the presence of H. pylori, the addition of interleukin-1 had no effect on the suppressed lymphoproliferation. Cell-separation and cell-mixing experiments indicated that an influence on monocytes rather than on T cells is the major cause of the observed suppressive effect. Although the immunological mechanisms involved in H. pylori-associated gastritis are not clearly defined, it is reasonable to presume that suppression of host defense mechanisms may contribute to the pathogenesis of this disease.

Citing Articles

Lymphocyte proliferative response to Helicobacter pylori antigens in H. pylori-infected patients.

Hybenova M, Hrda P, Potuznikova B, Pavlik E, Stejskal V, Dosedel J Folia Microbiol (Praha). 2011; 55(6):649-56.

PMID: 21253914 DOI: 10.1007/s12223-010-0105-7.


Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori.

Kranzer K, Eckhardt A, Aigner M, Knoll G, Deml L, Speth C Infect Immun. 2004; 72(8):4416-23.

PMID: 15271898 PMC: 470701. DOI: 10.1128/IAI.72.8.4416-4423.2004.


IFN-gamma synergizes with TNF-alpha but not with viable H. pylori in up-regulating CXC chemokine secretion in gastric epithelial cells.

Kraft M, Riedel S, Maaser C, Kucharzik T, Steinbuechel A, Domschke W Clin Exp Immunol. 2001; 126(3):474-81.

PMID: 11737065 PMC: 1906237. DOI: 10.1046/j.1365-2249.2001.01634.x.


Modulation of innate cytokine responses by products of Helicobacter pylori.

Meyer F, Wilson K, James S Infect Immun. 2000; 68(11):6265-72.

PMID: 11035734 PMC: 97708. DOI: 10.1128/IAI.68.11.6265-6272.2000.


Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response.

Whary M, Morgan T, Dangler C, Gaudes K, Taylor N, Fox J Infect Immun. 1998; 66(7):3142-8.

PMID: 9632578 PMC: 108325. DOI: 10.1128/IAI.66.7.3142-3148.1998.


References
1.
Markwell M, Haas S, Bieber L, Tolbert N . A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978; 87(1):206-10. DOI: 10.1016/0003-2697(78)90586-9. View

2.
FLOERSHEIM G, Hopff W, Gasser M, Bucher K . Impairment of cell-mediated immune responses by Pseudomonas aeruginosa. Clin Exp Immunol. 1971; 9(2):241-7. PMC: 1713021. View

3.
Goodwin C, Blincow E, Peterson G, Sanderson C, Cheng W, Marshall B . Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa. J Infect Dis. 1987; 155(3):488-94. DOI: 10.1093/infdis/155.3.488. View

4.
Mai U, Perez-Perez G, Wahl L, Wahl S, Blaser M, Smith P . Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest. 1991; 87(3):894-900. PMC: 329879. DOI: 10.1172/JCI115095. View

5.
Graham D, KLEIN P . Campylobacter pyloridis gastritis: the past, the present, and speculations about the future. Am J Gastroenterol. 1987; 82(4):283-6. View